DANIELLE SCHMACHTENBERGER: Open Payments
NPI 1538119177 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 11 payments from 9 companies in 2025. Trend: 2023 $491 · 2024 $242 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. | 2 | $55 |
| Lilly USA, LLC | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Eisai Inc. | 1 | $25 |
| EMD Serono, Inc. | 1 | $21 |
| GENZYME CORPORATION | 1 | $21 |
| SpringWorks Therapeutics, Inc. | 1 | $20 |
Products named: BRUKINSA, VERZENIO, ICLUSIG, KEYTRUDA, Lenvima, SARCLISA, OGSIVEO.
Industry payments across MI — which companies pay providers there.
